NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
January 21, 2026 — Oncotelic Therapeutics unveils nanotech platform at SABCS 2025, transforming drug delivery for cancer treatments with Sapu Nano and Deciparticle technology.
January 21, 2026 — LIXTE Biotechnology sponsors Good Health Summit with De La Soul at Morehouse College, advancing health equity through cultural engagement and cancer research innovation.
January 21, 2026 — Scientists at Southampton University develop new antibodies that boost the immune system's cancer-killing ability, enhancing immunotherapy effectiveness. Learn how this innovation could transform cancer treatment.
January 21, 2026 — AHA's 2026 report shows heart disease & stroke deaths declined but remain the #1 & #4 U.S. killers. Alarming rise in young adult stroke deaths & nearly 90% have early CKM syndrome risk.
January 21, 2026 — Optimum Pest Control offers professional cockroach removal in NYC with eco-friendly solutions. Learn about health risks and tailored treatments for infestations.
January 21, 2026 — Protheragen offers comprehensive drug analysis services, including stability and impurity testing, to enhance pharmaceutical development and ensure regulatory compliance.
January 21, 2026 — Creative Biolabs expands liposomal formulation services for drug delivery, addressing encapsulation efficiency and stability challenges for proteins, small molecules, and vaccine adjuvants.
January 20, 2026 — Lixte Biotechnology announces CEO Geordan Pursglove will present LB-100, a first-in-class cancer drug, at the 2026 DealFlow Discovery Conference, highlighting clinical trials and investor engagement.
January 20, 2026 — Austrian midwife Sarah Lares expands her organic baby brand The Midwife in Vienna to the US market, offering minimalist products backed by 20 years of clinical experience.
January 20, 2026 — Kairos Pharma (KAPA) announces participation in the DealFlow Discovery Conference in 2026, featuring its clinical-stage oncology programs and lead candidate ENV-105 targeting drug resistance in cancer.
January 20, 2026 — Lantern Pharma receives FDA Orphan Drug Designation for LP-284 in soft tissue sarcomas, expanding its AI-driven oncology pipeline and accelerating development for rare cancers.
January 20, 2026 — Earth Science Tech (ETST) transforms into a healthcare holding company with pharmaceutical and telemedicine focus. Learn about its regulatory alignment and growth strategy in this investor update.
January 20, 2026 — Scientists discover gut bacteria molecule Bac429 that boosts lung cancer immunotherapy response. Breakthrough could help patients resistant to current treatments. TinyGems reports on this immune-oncology advancement.
January 20, 2026 — AXIM Biotechnologies hires Dr. Alan Touch, a global regulatory leader and ocular diagnostic innovator, to enhance regulatory strategy and accelerate commercialization of its TearScan® platform.
January 20, 2026 — GeoVax Labs announces 2026 as a pivotal year with milestones for Mpox/smallpox vaccine GEO-MVA, cancer therapy Gedeptin®, and COVID-19 vaccine GEO-CM04S1. Learn about regulatory progress and scalable manufacturing.
January 20, 2026 — Emergency physician Gianluca Cerri MD advocates for system-based leadership in healthcare to address rural hospital closures, opioid crises, and medical errors. Learn about early intervention strategies.
January 19, 2026 — Inclusive Therapy Group provides affirming couples therapy for LGBTQIA+, polyamorous & diverse relationships. Improve communication & intimacy with specialized counselors.
January 19, 2026 — Neutra Corp projects 1000% revenue growth after pivoting to clinical research through subsidiary Neutra Life Sciences, now partnered with Parexel's Emerging Site Program for accelerated trial capabilities.
January 19, 2026 — Blue Faery hosts a free online Love Your Liver workshop for Black History Month on Feb 5, 2026. Learn about liver cancer prevention & disparities in Black communities from expert Dr. Rebecca Jones.
January 19, 2026 — Ozempic price comparison reveals $700+ savings through SaveRxCanada.to vs. U.S. retail pharmacies. International sourcing offers medication at $280 per pen versus $900+ in the U.S.